Showing results (2011-2020 of 6,943) with videos related to
Sort By:
Pageof 695
Cancer Science|December 22, 2021
FZD10-targeted α-radioimmunotherapy with 225 Ac-labeled OTSA101 achieves complete remission in a synovial sarcoma modelHitomi Sudo, Atsushi B Tsuji, Aya Sugyo, et al.Cancer Science|November 28, 2021
E239K mutation abolishes the suppressive effects of lysine-specific demethylase 1 on migration and invasion of MCF7 cellsYu Zhang, Tong Wu, Bo Zhao, et al.Cancer Science|December 2, 2021
LS-106, a novel EGFR inhibitor targeting C797S, exhibits antitumor activities both in vitro and in vivoYingqiang Liu, Mengzhen Lai, Shan Li, et al.Cancer Science|September 2, 2022
Ciltacabtagene autoleucel in patients with relapsed/refractory multiple myeloma: CARTITUDE-1 (phase 2) Japanese cohortMasaki Ri, Kenshi Suzuki, Tadao Ishida, et al.Cancer Science|September 2, 2022
Inhibition of insulin-like growth factor-1 receptor enhances eribulin-induced DNA damage in colorectal cancerTomoyasu Yoshihiro, Hiroshi Ariyama, Kyoko Yamaguchi, et al.Cancer Science|September 3, 2022
CDCA7 promotes TGF-β-induced epithelial-mesenchymal transition via transcriptionally regulating Smad4/Smad7 in ESCCHongyi Li, Shaojie Wang, Xiubo Li, et al.Cancer Science|September 3, 2022
Combination therapy of lymphatic drug delivery and total body irradiation in a metastatic lymph node and lung mouse modelShota Sora, Ariunbuyan Sukhbaatar, Shinichi Fukushige, et al.Cancer Science|September 17, 2022
Genetic predisposition to lung adenocarcinoma outcome is a feature already present in patients' noninvolved lung tissueFrancesca Minnai, Sara Noci, Marco Chierici, et al.Cancer Science|September 17, 2022
ROS inhibits RORα degradation by decreasing its arginine methylation in liver cancerHyuntae Im, Hee-Ji Baek, Eunbi Yang, et al.Cancer Science|December 9, 2021
Clinical characterization and immunosuppressive regulation of CD161 (KLRB1) in glioma through 916 samplesWang Di, Wenhua Fan, Fan Wu, et al.Pageof 695